Cargando…

Impact of lymphovascular invasion on recurrence and progression rates in patients with pT1 urothelial carcinoma of bladder after transurethral resection

OBJECTIVE: To evaluate the clinical significance of lymphovascular invasion (LVI) on recurrence and progression rates in patients with pT1 urothelial carcinoma of bladder after transurethral resection. METHODS: This retrospective study was performed with 155 patients with newly diagnosed pT1 urothel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sha, Nan, Xie, Linguo, Chen, Tao, Xing, Chen, Liu, Xiaoteng, Zhang, Yu, Shen, Zhonghua, Xu, Hao, Wu, Zhouliang, Hu, Hailong, Wu, Changli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655960/ https://www.ncbi.nlm.nih.gov/pubmed/26604797 http://dx.doi.org/10.2147/OTT.S95609

Ejemplares similares

Impact of squamous and/or glandular differentiation on recurrence and progression following transurethral resection for non-muscle invasive urothelial carcinoma of bladder
por: Xu, Hao, et al.
Publicado: (2017)

AB180. Impact of lymphovascular invasion on recurrence and progression rates in patients with pT1 urothelial carcinoma of bladder after transurethral resection
por: Sha, Nan, et al.
Publicado: (2016)

Risk Factors Predictive of Recurrence and Progression for Patients Who Suffered Initial Recurrence After Transurethral Resection of Stage pT1 Bladder Tumor in Chinese Population: A Retrospective Study
por: Shen, Zhonghua, et al.
Publicado: (2016)

Intravenous chemotherapy combined with intravesical chemotherapy to treat T1G3 bladder urothelial carcinoma after transurethral resection of bladder tumor: results of a retrospective study
por: Zhang, Yu, et al.
Publicado: (2016)

AB176. Impact of squamous and/or glandular differentiation on recurrence and progression after transurethral resection for non-muscle invasive urothelial carcinoma of bladder
por: Xu, Hao, et al.
Publicado: (2016)

The value of extensive transurethral resection in the diagnosis and treatment of nonmuscle invasive bladder cancer with respect to recurrence at the first follow-up cystoscopy
por: Qie, Yunkai, et al.
Publicado: (2016)

AB058. Intravenous chemotherapy combined with intravesical chemotherapy to treat T1G3 bladder urothelial carcinoma after transurethral resection of bladder tumor: results of a retrospective study
por: Zhang, Yu, et al.
Publicado: (2016)

The comparison of perioperative outcomes of robot-assisted and open partial nephrectomy: a systematic review and meta-analysis
por: Shen, Zhonghua, et al.
Publicado: (2016)

AB182. The value of extensive transurethral resection in the diagnosis and treatment of non-muscle invasive bladder cancer with respect to the recurrence at the first follow-up cystoscopy
por: Qie, Yunkai, et al.
Publicado: (2016)

Impact of Lymphovascular Invasion on Prognosis in the Patients with Bladder Cancer—Comparison of Transurethral Resection and Radical Cystectomy
por: Yoneda, Kei, et al.
Publicado: (2021)

Slingshot homolog-1 expression is a poor prognostic factor of pT1 bladder urothelial carcinoma after transurethral resection
por: Luo, Qiang, et al.
Publicado: (2020)

A systematic review and meta‐analysis of the impact of lymphovascular invasion in bladder cancer transurethral resection specimens
por: Mari, Andrea, et al.
Publicado: (2018)

Poor prognostic value of lymphovascular invasion for pT1 urothelial carcinoma with squamous differentiation in bladder cancer
por: Li, Gang, et al.
Publicado: (2016)

Preoperative hemoglobin-platelet ratio can significantly predict progression and mortality outcomes in patients with T1G3 bladder cancer undergoing transurethral resection of bladder tumor
por: Tang, Gang, et al.
Publicado: (2018)

A Case of Early Stage Bladder Carcinosarcoma in Late Recurrence of Urothelial Carcinoma after Transurethral Resection
por: Hirano, Daisaku, et al.
Publicado: (2018)

Histopathologic Evolution of Urothelial Carcinoma Recurrence in Transurethral Resection of the Urinary Bladder:35 Consecutive Cases And Literature Review
por: Koyuncuer, Ali
Publicado: (2017)

Comparison of Pathological Outcome and Recurrence Rate between En Bloc Transurethral Resection of Bladder Tumor and Conventional Transurethral Resection: A Meta-Analysis
por: Wang, Chi-Wei, et al.
Publicado: (2023)

Extensive rhabdomyosarcomatous differentiation in recurrent low-grade urothelial carcinoma of the bladder after transurethral resection: a case report
por: Kamei, Maiko, et al.
Publicado: (2015)

Lymphovascular invasion status at transurethral resection of bladder tumors may predict subsequent poor response of T1 tumors to bacillus Calmette-Guérin
por: Fukumoto, Keishiro, et al.
Publicado: (2016)

Is there a role for second transurethral resection in pTa high-grade urothelial bladder cancer?
por: Dangi, Anuj Deep, et al.
Publicado: (2018)

Transurethral needle electrode resection and transurethral holmium laser resection of bladder cancer
por: Zhou, Yu, et al.
Publicado: (2020)

Stromal Lymphoid Response Status in Micropapillary Urothelial Carcinomas Diagnosed in Bladder Transurethral Resections and its Comparison with Conventional Urothelial Carcinomas
por: Hacıhasanoğlu, Ezgi, et al.
Publicado: (2021)

Oncological safety of simultaneous transurethral resection of high-grade urothelial carcinoma of the bladder and benign prostatic hyperplasia
por: Sionov, Ben Valery, et al.
Publicado: (2022)

Management of bladder pheochromocytoma by transurethral resection
por: Sharma, Aditya P., et al.
Publicado: (2019)

Transurethral resection of bladder tumour (TURBT)
por: Kim, Lawrence H. C., et al.
Publicado: (2020)

A novel transurethral resection technique for superficial bladder tumor: retrograde en bloc resection
por: Zhang, Kai-Yan, et al.
Publicado: (2017)

AB265. Association between MDM2 SNP309T>G polymorphism and the risk of bladder cancer: new data in Chinese population and an update meta-analysis
por: Xie, Linguo, et al.
Publicado: (2016)

Transurethral resection syndrome: A rare complication of intraperitoneal bladder perforation during transurethral resection of bladder tumor
por: Ibrahimi, Ahmed, et al.
Publicado: (2020)

Comparison of the efficacy and feasibility of en bloc transurethral resection of bladder tumor versus conventional transurethral resection of bladder tumor: A meta-analysis
por: Wu, Yu-Peng, et al.
Publicado: (2016)

Down-staging (<pT2) of urothelial cancer at cystectomy after the diagnosis of detrusor muscle invasion (pT2) at diagnostic transurethral resection (TUR): is prediction possible?
por: Beukers, Willemien, et al.
Publicado: (2012)

The prognostic value of preoperative serum albumin in patients with bladder urothelial carcinoma undergoing transurethral resection of bladder tumor: A prospective cohort study
por: Shen, Chen, et al.
Publicado: (2021)

Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients
por: Shen, Chong, et al.
Publicado: (2020)

Clinical determinants of recurrence in pTa bladder cancer following transurethral resection of bladder tumor
por: Jeong, Seung-hwan, et al.
Publicado: (2022)

Lack of evidence for increased level of circulating urothelial cells in the peripheral blood after transurethral resection of bladder tumors
por: Antoniewicz, Artur A., et al.
Publicado: (2011)

Association between MDM2 SNP309 T>G polymorphism and the risk of bladder cancer: new data in a Chinese population and an updated meta-analysis
por: Xie, Linguo, et al.
Publicado: (2015)

Utility of restage transurethral resection of bladder tumor
por: Manoharan, Vignesh, et al.
Publicado: (2018)

Technical developments in transurethral resection of bladder tumours
por: Pastuszak, Agata, et al.
Publicado: (2019)

Bladder injury secondary to obturator reflex is more common with plasmakinetic transurethral resection than monopolar transurethral resection of bladder cancer
por: Ozer, Kutan, et al.
Publicado: (2015)

Extraperitoneal bladder perforation secondary to transurethral resection of bladder tumor
por: Luu, Doan Tien, et al.
Publicado: (2021)

AB175. Girdin protein is a novel prognosis predictor for patients with non-muscle invasive bladder cancer
por: Wu, Zhouliang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_239jpspntfbgvpubvf4rdgiaf4